Massive 5,000-Person study tracks safety of new chikungunya shot
NCT ID NCT07254702
Summary
This study is carefully watching for side effects in 5,000 people in Brazil who have already received a new vaccine for chikungunya virus. The main goal is to understand how common certain health concerns are after vaccination, including heart issues and joint pain. Researchers will follow participants for several months to gather safety information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro de Pesquisas Clínicas Universidade Federal Sergipe, Hospital e Maternidade São João de Deus
Laranjeiras, Sergipe, 49060-025, Brazil
-
Fundação Faculdade Regional De Medicina De São José Do Rio Preto
São Pedro, São Paulo, 15090-000, Brazil
-
Universidade Federal Do Ceará
Fortaleza, Ceará, 60430-160, Brazil
-
Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras
Belo Horizonte, Minas Gerais, 31270-901, Brazil
Conditions
Explore the condition pages connected to this study.